These data suggest CNS insulin resistance, as occurs in AD [33], is not likely to impact the therapeutic delivery of IN insulin, similar to what we have previously shown in the SAMP8 mouse model of AD [30]. This evidence concerns the gene INS and Alzheimer disease.